These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 25307226)

  • 21. Neurocircuitry involved in the development of alcohol addiction: the dopamine system and its access points.
    Söderpalm B; Ericson M
    Curr Top Behav Neurosci; 2013; 13():127-61. PubMed ID: 22094880
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Molecular neurobiological research in the fight against drug abuse].
    Terenius L
    Lakartidningen; 1991 Jul; 88(30-31):2526-30. PubMed ID: 1650871
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Reconsideration of nicotine and other substance dependence: a clue from dependence-related mentation including reward, motivation, learning, delusion and hallucination toward understanding the concept of non-substance-related addiction].
    Miyata H
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2013 Nov; 33(5-6):191-7. PubMed ID: 25069257
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kappa opioids as potential treatments for stimulant dependence.
    Prisinzano TE; Tidgewell K; Harding WW
    AAPS J; 2005 Oct; 7(3):E592-9. PubMed ID: 16353938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inter/Transgenerational Effects of Drugs of Abuse: A Scoping Review.
    Sadat-Shirazi MS; Sadeghi-Adl M; Akbarabadi A; Ashabi G; Mokri A; Zarrindast MR
    CNS Neurol Disord Drug Targets; 2023; 22(4):512-538. PubMed ID: 35507779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse/addiction and/or aberrant drug-related behaviors? A structured evidence-based review.
    Fishbain DA; Cole B; Lewis J; Rosomoff HL; Rosomoff RS
    Pain Med; 2008; 9(4):444-59. PubMed ID: 18489635
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protracted abstinence from distinct drugs of abuse shows regulation of a common gene network.
    Le Merrer J; Befort K; Gardon O; Filliol D; Darcq E; Dembele D; Becker JA; Kieffer BL
    Addict Biol; 2012 Jan; 17(1):1-12. PubMed ID: 21955143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discovery of a novel site of opioid action at the innate immune pattern-recognition receptor TLR4 and its role in addiction.
    Jacobsen JH; Watkins LR; Hutchinson MR
    Int Rev Neurobiol; 2014; 118():129-63. PubMed ID: 25175864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of neuroimmune activation induced by alcohol or drug abuse on adolescent brain development.
    Guerri C; Pascual M
    Int J Dev Neurosci; 2019 Oct; 77():89-98. PubMed ID: 30468786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic opioids: a ten-year perspective on the complexities and complications of the escalating use, abuse, and nonmedical use of opioids.
    Manchikanti L; Singh A
    Pain Physician; 2008 Mar; 11(2 Suppl):S63-88. PubMed ID: 18443641
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Neurobiology of addiction to drugs of abuse].
    Gil-Verona JA; Pastor JF; de Paz F; Barbosa M; Macias-Fernández JA; Maniega MA; Rami-González L; Cañizares-Alejos S
    Rev Neurol; 2003 Feb 15-28; 36(4):361-5. PubMed ID: 12599136
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of glial cells in drug abuse.
    Miguel-Hidalgo JJ
    Curr Drug Abuse Rev; 2009 Jan; 2(1):72-82. PubMed ID: 19630738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The opioid system and food intake: homeostatic and hedonic mechanisms.
    Nogueiras R; Romero-Picó A; Vazquez MJ; Novelle MG; López M; Diéguez C
    Obes Facts; 2012; 5(2):196-207. PubMed ID: 22647302
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stimulus properties of nicotine, amphetamine, and chlordiazepoxide as positive features in a pavlovian appetitive discrimination task in rats.
    Palmatier MI; Wilkinson JL; Metschke DM; Bevins RA
    Neuropsychopharmacology; 2005 Apr; 30(4):731-41. PubMed ID: 15592350
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of the endogenous cannabinoid system in drug addiction.
    Parolaro D; Rubino T
    Drug News Perspect; 2008 Apr; 21(3):149-57. PubMed ID: 18560613
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amphetamines: pharmacology, abuse and addiction.
    Miller NS; Millman RB; Gold MS
    Adv Alcohol Subst Abuse; 1989; 8(2):53-69. PubMed ID: 2546376
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prescription opioid abuse in chronic pain: a review of opioid abuse predictors and strategies to curb opioid abuse.
    Sehgal N; Manchikanti L; Smith HS
    Pain Physician; 2012 Jul; 15(3 Suppl):ES67-92. PubMed ID: 22786463
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Neurobiology of substance-related addiction: findings of neuroimaging].
    Kienast T; Wrase J; Heinz A
    Fortschr Neurol Psychiatr; 2008 May; 76 Suppl 1():S68-76. PubMed ID: 18461548
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulation of alcohol and nicotine responses through the endogenous opioid system.
    Drews E; Zimmer A
    Prog Neurobiol; 2010 Jan; 90(1):1-15. PubMed ID: 19800387
    [TBL] [Abstract][Full Text] [Related]  

  • 40. From neurobiology to treatment: progress against addiction.
    Nestler EJ
    Nat Neurosci; 2002 Nov; 5 Suppl():1076-9. PubMed ID: 12403990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.